FDA approves Alzheimers drug Leqembi paving way for broader Medicare coverage - Stock Check Updates

Breaking

Thursday, July 6, 2023

FDA approves Alzheimers drug Leqembi paving way for broader Medicare coverage

Leqembi slowed cognitive decline in a clinical trial, but the treatment is expensive and carries serious risks of brain swelling and bleeding.

from International: Top News And Analysis https://ift.tt/HKf5I7D
via IFTTT

No comments:

Post a Comment